Invizius named one of “Fierce 15” Med Tech Companies of 2018
- On February 28, 2019
- By GrowthInvest Admin
Invizius has developed H-GuardTM, a biotechnology product that acts as an “invisibility cloak”, hiding life-saving medical devices from patients’ immune systems. The company’s first application targets the blood filter used in kidney dialysis, promising to meet a massive and desperate unmet need among almost three million patients with kidney failure. The company spun out of ground-breaking research at the University of Edinburgh into how deadly bacteria manage to hide from the human immune system. H-GuardTM replicates bacteria’s behaviour and is being developed into a suite of products that integrate with existing treatments, preventing the deadly complications that result when medical devices are rejected.
For further information and to read the full article, please click here
GET IN TOUCH!
MAIL US
enquiries@growthinvest.comCALL US
020 7071 3945FOLLOW US ON
Throughout our site you will find links to external websites. Although we make every effort to ensure these links are accurate, up to date and relevant, we cannot take responsibility for pages maintained by external providers.
GrowthInvest is a trading name of EIS Platforms Limited. EIS Platforms Limited (FRN: 694945) is an appointed representative of Sapphire Capital Partners LLP (FRN:565716) which is authorised and regulated by the Financial Conduct Authority in the UK.
All rights reserved 2024 @ growthinvest